Paolo Serafini

Paolo Serafini

UNVERIFIED PROFILE

Are you Paolo Serafini?   Register this Author

Register author
Paolo Serafini

Paolo Serafini

Publications by authors named "Paolo Serafini"

Are you Paolo Serafini?   Register this Author

34Publications

502Reads

16Profile Views

Optimized Clinical Decision-making: A Configurable Markov Model for Benign Prostatic Hyperplasia Treatment.

Urology 2019 Oct 26;132:183-188. Epub 2019 Jun 26.

Università degli Studi di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.06.022DOI Listing
October 2019

4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells.

J Immunol 2017 05 10;198(10):4166-4177. Epub 2017 Apr 10.

Department of Microbiology and Immunology, University of Miami, Miami, FL, 33136;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1600833DOI Listing
May 2017

Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy.

Vaccines (Basel) 2016 Sep 9;4(3). Epub 2016 Sep 9.

Department of Microbiology Immunology, University of Miami, Miami, FL 33146, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041025PMC
http://dx.doi.org/10.3390/vaccines4030031DOI Listing
September 2016

Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion.

Eur J Immunol 2014 Nov 18;44(11):3307-19. Epub 2014 Oct 18.

Diabetes Research Institute, University of Miami, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201444522DOI Listing
November 2014

FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma.

PLoS One 2013 20;8(8):e71908. Epub 2013 Aug 20.

Department of Otolaryngology, University of Miami, Miller School of Medicine, Miami, Florida, United States of America ; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071908PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748098PMC
April 2014

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.

Authors:
Paolo Serafini

Immunol Res 2013 Dec;57(1-3):172-84

Department of Microbiology and Immunology, University of Miami, Miller School of Medicine, RMSB 3075, 1600 NW 10th Avenue, Miami, FL, 33136, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-013-8455-2DOI Listing
December 2013

The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.

Immunol Res 2013 Dec;57(1-3):52-69

University of Miami Miller School of Medicine, 1475 NW 12th Avenue, 3rd Flr, Suite 3550, Miami, FL, 33136, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12026-013-8462-3
Publisher Site
http://dx.doi.org/10.1007/s12026-013-8462-3DOI Listing
December 2013

Exact solution of the robust knapsack problem.

Comput Oper Res 2013 Nov;40(11):2625-2631

DEI, University of Padova, Via Gradenigo 6/A, I-35131 Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cor.2013.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727332PMC
November 2013

Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.

Cancer Res 2012 Mar 26;72(6):1373-83. Epub 2012 Jan 26.

Department of Microbiology and Immunology, Sylvester Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2772DOI Listing
March 2012

Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells.

Cancer Res 2011 Dec 10;71(24):7452-62. Epub 2011 Oct 10.

Department of Microbiology and Immunology, Sylvester Cancer Center, Miller School of Medicine, University of Miami, Miami, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-1766DOI Listing
December 2011

Editorial: PGE2-producing MDSC: a role in tumor progression?

Authors:
Paolo Serafini

J Leukoc Biol 2010 Nov;88(5):827-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0510303DOI Listing
November 2010

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

Cancer Res 2008 Jul;68(13):5439-49

Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute, University of Miami, School of Medicine, Miami, Florida 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887390PMC
July 2008

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

Immunol Rev 2008 Apr;222:162-79

Department of Oncology and Surgical Sciences, Padova University, Padova, Italy, and Venetian Institute for Molecular Medicine, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-065X.2008.00602.xDOI Listing
April 2008

Balance lower limb loads and 3D spine modifications after total hip joint replacement: effects of leg length discrepancy correction.

Stud Health Technol Inform 2006 ;123:409-14

Istituto di Riabilitazione S. Stefano, Via Aprutina 194 Porto Potenza Picena (MC), Italy.

View Article

Download full-text PDF

Source
January 2007

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

J Exp Med 2006 Nov 13;203(12):2691-702. Epub 2006 Nov 13.

Sidney Kimmel Comprehensive Cancer Center, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20061104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118163PMC
November 2006

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

Semin Cancer Biol 2006 Feb 15;16(1):53-65. Epub 2005 Sep 15.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1044579X0500058
Publisher Site
http://dx.doi.org/10.1016/j.semcancer.2005.07.005DOI Listing
February 2006

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors.

Cancer Res 2005 Mar;65(5):2026-34

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-3337DOI Listing
March 2005

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Cancer Res 2004 Sep;64(17):6337-43

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-0757DOI Listing
September 2004

Derangement of immune responses by myeloid suppressor cells.

Cancer Immunol Immunother 2004 Feb 30;53(2):64-72. Epub 2003 Oct 30.

Department of Oncology and Surgical Sciences, Oncology Section, Azienda Ospedaliera, Via Gattamelata 64, 35128, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-003-0443-2DOI Listing
February 2004

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

Trends Immunol 2003 Jun;24(6):302-6

Department of Oncology and Surgical Sciences, Via Gattamelata 64, 35128, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1471-4906(03)00132-7DOI Listing
June 2003

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

J Immunol 2002 Jan;168(2):689-95

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892. Department of Oncology and Surgical Sciences, Oncology Section, Azienda Ospedaliera, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.2.689DOI Listing
January 2002